Want to track RGC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Regencell Bioscience Holdings Limited (RGC) Statistics
Valuation metrics
Market Cap 4.76B
Enterprise value 3.79B
Trailing P/E (ttm) -325
Forward P/E -
PEG ratio 3.28
Price/Sales (ttm) -
Price/Book (mrq) 284.23
Enterprise Value/Revenue -
Enterprise Value/EBITDA -334.77
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 684.08K
Average volume (90 days) 244.58K
Price summary
52-Week low 4.51
52-Week high 69
Beta -
50-Day moving average 7.14
200-Day moving average 13.61
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 38:1
Last split Date 16 Jun 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.79%
Return on equity -1.61%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.02
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.03
Total debt (mrq) -
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 10.77%
Book value per share (mrq) 0.03
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
